• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎中,1型和2型病毒感染患者的治疗前病毒血症水平与α干扰素治疗反应之间的关系有所不同。

Relationship between pretreatment viremia level and response to interferon-alpha therapy in chronic hepatitis C differs in viral type 1 and 2 infections.

作者信息

Tsubota A, Kumada H, Chayama K, Arase Y, Saitoh S, Koida I, Murashima N, Suzuki Y, Kobayashi M, Takagi K, Kobayashi M, Ikeda K

机构信息

Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.

出版信息

Dig Dis Sci. 1996 Oct;41(10):1925-32. doi: 10.1007/BF02093591.

DOI:10.1007/BF02093591
PMID:8888702
Abstract

To determine the contribution of virus-related factors to long-term remission of chronic hepatitis C infection, we analyzed viral type and viremia level in 185 patients who had undergone a six-month course of interferon-alpha therapy. These virus-related factors were measured by an enzyme-linked immunosorbent assay with use of viral type-specific antigens and the branched DNA (bDNA) signal amplification assay, respectively. Sustained and long-term sustained responses were achieved in 55% and 50% of the patients, respectively. Transient or no responses were observed in 30% and 15% of the patients, respectively. Thirty-five percent of viral type 1 patients and 82% of viral type 2 patients had long-term sustained responses. Forty-two percent of bDNA-positive and 71% of bDNA-negative patients experienced long-term sustained responses. On multivariate analysis, viral type, Knodell's intralobular score, and viremia level were strong independent predictors of long-term sustained response (P < 0.0001, = 0.0060, and 0.037, respectively). Viremia level, however, was a significant predictor only in viral type 1, not type 2, patients. The relation between pretreatment viremia level and response to interferon-alpha therapy in chronic hepatitis C differs in viral type 1 and 2 infections.

摘要

为了确定病毒相关因素对慢性丙型肝炎感染长期缓解的作用,我们分析了185例接受了为期6个月的α干扰素治疗患者的病毒类型和病毒血症水平。这些病毒相关因素分别通过使用病毒类型特异性抗原的酶联免疫吸附测定和分支DNA(bDNA)信号扩增测定来测量。分别有55%和50%的患者实现了持续和长期持续应答。分别有30%和15%的患者观察到短暂或无应答。1型病毒患者中有35%以及2型病毒患者中有82%获得了长期持续应答。bDNA阳性患者中有42%以及bDNA阴性患者中有71%经历了长期持续应答。多变量分析显示,病毒类型、Knodell小叶内评分和病毒血症水平是长期持续应答的强有力独立预测因素(P分别<0.0001、=0.0060和0.037)。然而,病毒血症水平仅是1型病毒而非2型病毒患者的显著预测因素。慢性丙型肝炎患者治疗前病毒血症水平与对α干扰素治疗反应之间的关系在1型和2型病毒感染中有所不同。

相似文献

1
Relationship between pretreatment viremia level and response to interferon-alpha therapy in chronic hepatitis C differs in viral type 1 and 2 infections.慢性丙型肝炎中,1型和2型病毒感染患者的治疗前病毒血症水平与α干扰素治疗反应之间的关系有所不同。
Dig Dis Sci. 1996 Oct;41(10):1925-32. doi: 10.1007/BF02093591.
2
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.丙型肝炎病毒感染中预测干扰素-α治疗反应的因素。
Hepatology. 1994 May;19(5):1088-94.
3
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.法国和意大利的1b型(II型)丙型肝炎病毒感染。协作研究组
Ann Intern Med. 1995 Feb 1;122(3):161-8. doi: 10.7326/0003-4819-122-3-199502010-00001.
4
Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.采用第二代分支DNA探针检测法测定丙型肝炎病毒(HCV)RNA水平,以此作为慢性HCV病毒血症患者对干扰素治疗反应的预测指标。
Dig Dis Sci. 2002 Mar;47(3):535-42. doi: 10.1023/a:1017955700585.
5
Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.采用分支DNA探针法和竞争性逆转录聚合酶链反应比较慢性丙型肝炎患者血清丙型肝炎病毒RNA浓度,以此作为干扰素-α治疗反应的预测指标。
J Med Virol. 1996 Apr;48(4):354-9. doi: 10.1002/(SICI)1096-9071(199604)48:4<354::AID-JMV9>3.0.CO;2-6.
6
Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.慢性丙型肝炎的治疗前病毒载量及对延长疗程干扰素-α治疗的反应
J Hepatol. 1995 Apr;22(4):457-63. doi: 10.1016/0168-8278(95)80109-x.
7
[Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].[慢性丙型肝炎患者使用α干扰素治疗期间血清丙型肝炎病毒血症快速转阴的预测价值]
Pathol Biol (Paris). 1996 May;44(5):468-72.
8
Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.持续性丙型肝炎病毒血症可预测慢性丙型肝炎患者对α干扰素持续应答后的晚期复发。威尼托大区病毒性肝炎研究组
Ann Intern Med. 1996 Jun 15;124(12):1058-60. doi: 10.7326/0003-4819-124-12-199606150-00005.
9
Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.慢性肝病中的丙型肝炎病毒血症:与α干扰素或皮质类固醇治疗的关系。
Hepatology. 1994 Feb;19(2):273-9.
10
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.慢性丙型肝炎患者血清丙型肝炎病毒RNA水平的意义
Lancet. 1993 Jun 12;341(8859):1501-4. doi: 10.1016/0140-6736(93)90635-t.

引用本文的文献

1
Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.聚乙二醇干扰素α联合利巴韦林治疗基因2型慢性丙型肝炎时的干扰素λ3基因多态性
World J Gastroenterol. 2015 Apr 7;21(13):3904-11. doi: 10.3748/wjg.v21.i13.3904.
2
Peginterferon and ribavirin treatment for hepatitis C virus infection.聚乙二醇干扰素和利巴韦林治疗丙型肝炎病毒感染。
World J Gastroenterol. 2011 Jan 28;17(4):419-32. doi: 10.3748/wjg.v17.i4.419.
3
Four-week pegylated interferon alpha-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: a pilot, randomized study.

本文引用的文献

1
Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group.
J Infect Dis. 1996 Mar;173(3):727-30. doi: 10.1093/infdis/173.3.727.
2
Genotypic subtyping of hepatitis C virus.丙型肝炎病毒的基因分型
J Gastroenterol Hepatol. 1993 Mar-Apr;8(2):150-6. doi: 10.1111/j.1440-1746.1993.tb01507.x.
3
Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.重组α-2a干扰素治疗慢性丙型肝炎的随机对照试验。丙氨酸转氨酶正常化与丙型肝炎病毒RNA及抗丙型肝炎病毒IgM消失的比较。
聚乙二醇化干扰素α-2a单药治疗4周对基因2型、低病毒载量慢性丙型肝炎的疗效:一项前瞻性随机研究。
World J Gastroenterol. 2008 Dec 21;14(47):7220-4. doi: 10.3748/wjg.14.7220.
Dig Dis Sci. 1993 Apr;38(4):601-7. doi: 10.1007/BF01316787.
4
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy.干扰素α治疗期间血清中丙型肝炎病毒RNA的定量分析。
Gastroenterology. 1993 Mar;104(3):877-83. doi: 10.1016/0016-5085(93)91025-d.
5
Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.
Dig Dis Sci. 1994 Jun;39(6):1273-80. doi: 10.1007/BF02093793.
6
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.丙型肝炎病毒感染中预测干扰素-α治疗反应的因素。
Hepatology. 1994 May;19(5):1088-94.
7
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.慢性丙型肝炎患者血清丙型肝炎病毒RNA水平的意义
Lancet. 1993 Jun 12;341(8859):1501-4. doi: 10.1016/0140-6736(93)90635-t.
8
Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer.根据丙型肝炎病毒基因型和RNA滴度预测干扰素治疗效果。
Dig Dis Sci. 1994 May;39(5):977-82. doi: 10.1007/BF02087547.
9
Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.
Virology. 1993 Feb;192(2):430-7. doi: 10.1006/viro.1993.1058.
10
Implications of variations of "conserved" regions of hepatitis C virus genome.丙型肝炎病毒基因组“保守”区域变异的影响
Lancet. 1995 Aug 12;346(8972):425-6. doi: 10.1016/s0140-6736(95)92786-7.